Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion
Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion.
Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion.